# Exponent Inc: filings

EXPO · Nasdaq · CIK 851520 · [Industrials](/sectors/industrials.md) · fiscal year ends Jan 1

Pages: [Overview](/companies/expo.md) · [Financials](/companies/expo/financials.md) · [Filings](/companies/expo/filings.md) · [Insiders](/companies/expo/insiders.md)

## Reports and events: 207 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 976, 5 134, 8-K 111, SC 13G/A 71, 10-Q 53, 144 41, 4/A 26, 3 22, 10-K 18, DEF 14A 18, SC 13G 11, 5/A 9, UPLOAD 8, S-8 POS 7, 8-K/A 4, ARS 4, CORRESP 4, DEFA14A 4, SCHEDULE 13G/A 4, S-8 3, 10-K/A 2, PRE 14A 2, SCHEDULE 13G 2, 10-Q/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-07 | 16:02 ET | [10-Q](/filings/0001193125-26-340211.md) | Quarterly report, period 2026-07-03 | 0001193125-26-340211 |
| 2026-07-30 | 16:05 ET | [8-K](/filings/0001171843-26-005081.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-005081 |
| 2026-06-10 | 16:05 ET | [8-K](/filings/0001171843-26-004036.md) | 5.07 Shareholder vote results | 0001171843-26-004036 |
| 2026-05-08 | 16:00 ET | [10-Q](/filings/0001193125-26-214572.md) | Quarterly report, period 2026-04-03 | 0001193125-26-214572 |
| 2026-04-30 | 16:05 ET | [8-K](/filings/0001171843-26-002896.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-002896 |
| 2026-04-20 | 16:07 ET | [DEF 14A](/filings/0001193125-26-163945.md) | Proxy statement, period 2026-06-04 | 0001193125-26-163945 |
| 2026-04-06 | 16:35 ET | [8-K](/filings/0001171843-26-002263.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001171843-26-002263 |
| 2026-02-27 | 16:02 ET | [10-K](/filings/0001193125-26-082508.md) | Annual report, period 2026-01-02 | 0001193125-26-082508 |
| 2026-02-05 | 16:05 ET | [8-K](/filings/0001171843-26-000654.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-000654 |
| 2025-11-07 | 16:00 ET | [10-Q](/filings/0001193125-25-272273.md) | Quarterly report, period 2025-10-03 | 0001193125-25-272273 |
| 2025-10-30 | 16:05 ET | [8-K](/filings/0001171843-25-006835.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-25-006835 |
| 2025-08-08 | 16:00 ET | [10-Q](/filings/0000950170-25-105799.md) | Quarterly report, period 2025-07-04 | 0000950170-25-105799 |
| 2025-07-31 | 16:05 ET | [8-K](/filings/0001171843-25-004918.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-25-004918 |
| 2025-06-10 | 16:30 ET | [8-K](/filings/0001171843-25-003818.md) | 5.07 Shareholder vote results | 0001171843-25-003818 |
| 2025-05-09 | 16:03 ET | [10-Q](/filings/0000950170-25-067987.md) | Quarterly report, period 2025-04-04 | 0000950170-25-067987 |
| 2025-05-01 | 16:05 ET | [8-K](/filings/0001171843-25-002692.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-25-002692 |
| 2025-04-21 | 16:30 ET | [DEF 14A](/filings/0000950170-25-056320.md) | Proxy statement, period 2025-06-05 | 0000950170-25-056320 |
| 2025-04-18 | 16:12 ET | [10-K/A](/filings/0000950170-25-055867.md) | Annual report, amended, period 2025-01-03 | 0000950170-25-055867 |
| 2025-02-28 | 16:09 ET | [10-K](/filings/0000950170-25-030001.md) | Annual report, period 2025-01-03 | 0000950170-25-030001 |
| 2025-02-06 | 16:05 ET | [8-K](/filings/0001171843-25-000676.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-25-000676 |
| 2024-11-01 | 11:43 ET | [8-K](/filings/0000950170-24-119889.md) | 5.02 Departure or appointment of officers or directors | 0000950170-24-119889 |
| 2024-11-01 | 11:39 ET | [10-Q](/filings/0000950170-24-119886.md) | Quarterly report, period 2024-09-27 | 0000950170-24-119886 |
| 2024-10-24 | 16:05 ET | [8-K](/filings/0001171843-24-005815.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-24-005815 |
| 2024-08-02 | 16:05 ET | [10-Q](/filings/0000950170-24-089943.md) | Quarterly report, period 2024-06-28 | 0000950170-24-089943 |
| 2024-07-25 | 16:05 ET | [8-K](/filings/0001171843-24-004151.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-24-004151 |
| 2024-06-24 | 16:47 ET | [8-K](/filings/0000950170-24-076817.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000950170-24-076817 |
| 2024-06-11 | 16:45 ET | [8-K](/filings/0000950170-24-071983.md) | 5.07 Shareholder vote results | 0000950170-24-071983 |
| 2024-05-03 | 16:30 ET | [10-Q](/filings/0000950170-24-052966.md) | Quarterly report, period 2024-03-29 | 0000950170-24-052966 |
| 2024-04-25 | 16:05 ET | [8-K](/filings/0001171843-24-002240.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-24-002240 |
| 2024-04-22 | 16:58 ET | [DEF 14A](/filings/0000950170-24-046483.md) | Proxy statement, period 2024-06-06 | 0000950170-24-046483 |
| 2024-04-17 | 16:54 ET | [10-K/A](/filings/0000950170-24-045160.md) | Annual report, amended, period 2023-12-29 | 0000950170-24-045160 |
| 2024-03-01 | 16:12 ET | [8-K](/filings/0000950170-24-023858.md) | 5.02 Departure or appointment of officers or directors | 0000950170-24-023858 |
| 2024-02-23 | 16:17 ET | [10-K](/filings/0000950170-24-019390.md) | Annual report, period 2023-12-29 | 0000950170-24-019390 |
| 2024-02-08 | 19:51 ET | [8-K](/filings/0000950170-24-012433.md) | 5.02 Departure or appointment of officers or directors | 0000950170-24-012433 |
| 2024-02-01 | 16:05 ET | [8-K](/filings/0001171843-24-000521.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-24-000521 |
| 2023-11-03 | 16:36 ET | [10-Q](/filings/0000950170-23-058876.md) | Quarterly report, period 2023-09-29 | 0000950170-23-058876 |
| 2023-10-26 | 16:06 ET | [8-K](/filings/0001171843-23-006473.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-23-006473 |
| 2023-10-06 | 16:32 ET | [8-K](/filings/0000950170-23-052421.md) | 5.02 Departure or appointment of officers or directors | 0000950170-23-052421 |
| 2023-09-11 | 21:30 ET | [8-K/A](/filings/0000950170-23-047341.md) | 5.07 Shareholder vote results | 0000950170-23-047341 |
| 2023-08-07 | 18:20 ET | [10-Q](/filings/0000950170-23-038668.md) | Quarterly report, period 2023-06-30 | 0000950170-23-038668 |
| 2023-07-27 | 16:05 ET | [8-K](/filings/0001171843-23-004740.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-23-004740 |
| 2023-06-13 | 12:04 ET | [8-K](/filings/0000950170-23-027632.md) | 5.07 Shareholder vote results | 0000950170-23-027632 |
| 2023-05-05 | 17:07 ET | [10-Q](/filings/0000950170-23-018383.md) | Quarterly report, period 2023-03-31 | 0000950170-23-018383 |
| 2023-04-27 | 16:01 ET | [8-K](/filings/0001171843-23-002639.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-23-002639 |
| 2023-04-24 | 17:23 ET | [DEF 14A](/filings/0000950170-23-014141.md) | Proxy statement | 0000950170-23-014141 |
| 2023-02-24 | 16:53 ET | [10-K](/filings/0000950170-23-004401.md) | Annual report, period 2022-12-30 | 0000950170-23-004401 |
| 2023-02-17 | 13:41 ET | [8-K](/filings/0000950170-23-003171.md) | 5.02 Departure or appointment of officers or directors | 0000950170-23-003171 |
| 2023-02-02 | 16:01 ET | [8-K](/filings/0001171843-23-000631.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-23-000631 |
| 2022-12-19 | 18:08 ET | [8-K](/filings/0000950170-22-026691.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0000950170-22-026691 |
| 2022-11-04 | 16:26 ET | [10-Q](/filings/0000950170-22-022200.md) | Quarterly report, period 2022-09-30 | 0000950170-22-022200 |

Page 1 of 5. [Older](/companies/expo/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 16:06 ET. No prices; not investment advice.